World News
-
FDA approves first gene therapy for Wiskott-Aldrich syndrome
Waskyra is specifically indicated for pediatric patients aged six months and older, as well as adults diagnosed with WAS who have a mutation in the WAS gene.
-
Kenya to attend the WHO Traditional Medicine Summit in India for collaboration
The summit takes place in New Delhi from December 17 to 19 and will showcase India’s extensive experience in traditional and complementary medicine.
-
Singapore approves Respiree’s AI-powered patient monitoring system for detecting acute deterioration
The newly approved toolbox serves as a sophisticated aid for healthcare professionals who need to identify signs of acute deterioration in their inpatient populations.
-
-
AGC Biologics collaborates with ATUM to accelerate drug development via advanced cell line technology
AGC Biologics now offers the ATUM transposase-based platform as part of its growing portfolio of cell line development solutions.
-
MIT Jameel Clinic collaborates with Japan to test Cancer prediction AI Mirai
The partnership will begin with a study focused on assessing Mirai’s ability to predict breast cancer risk specifically in Japanese women using mammography images.
-
Takeda-Innovent closes USD11.4B immuno-oncology partnership
The two pharmaceutical giants originally signed the agreement in October 2025, establishing a framework centered on bispecific antibodies and ADCs.
-
Roche receives FDA clearance for rapid 15-minute pertussis PCR test
The test distinguishes between three distinct Bordetella species that cause different types of illness: B. pertussis, B. parapertussis and B. holmesii
-
The Herbal Divide: Why Asia embraces traditional medicine, while the West holds back
Herbal medicine is extremely popular among the Chinese public for both prevention and treatment, but unlike many Western countries, China has policies designed to address a growing disease burden among an aging population and wholeheartedly supports the use of herbal medicines.
-
FDA approves MED-EL SYNCHRONY cochlear implant for infants as young as seven months
The FDA’s latest decision also extends the audiologic and speech indications to children aged 12 months and older, broadening the potential patient population who can benefit from this technology.